The World Health Organization approved a new treatment for multi-drug resistant tuberculosis (MDR-TB) on Thursday, a crucial step towards replacing an old, costly therapy that is brutal on patients and only 50-percent effective.
May 12, 2016
0
1
While use of the standard therapy leading to the best outcome against locally advanced rectal cancer has increased over the past decade, only half of patients currently receive it, according to a new study. The authors of ...
Apr 13, 2016
0
3
Patients with Obsessive-Compulsive Disorder (OCD) can improve their symptoms significantly by adding exposure and response prevention therapy to their treatment regimen when common drug treatment options have failed, according ...
Nov 11, 2015
0
49
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug called Onivyde as part of a treatment regimen for advanced pancreatic cancer.
Oct 22, 2015
0
14
Research with human tissue and cells suggests that genetic variations, in addition to failure to comply with treatment regimens, may account for some failures of an anti-HIV drug to treat and prevent HIV infection.
Jul 9, 2015
0
11
Researchers from the University of Leicester and Leicester's Hospitals have discovered that many people suffering from type 2 diabetes also suffer from low blood sugar levels that can pose a significant risk to their health.
Jun 18, 2015
0
26
Since HIV emerged in the '80s, drug "cocktails" transformed the deadly disease into a manageable one. But the virus is adept at developing resistance to drugs, and treatment regimens require tweaking that can be costly. Now ...
Mar 18, 2015
0
53
By looking at the expression levels of downstream genes of the regulators in breast cancer, investigators at Dartmouth Hitchcock's Norris Cotton Cancer Center (NCCC), led by Chao Cheng, PhD, have identified a gene signature ...
Jan 7, 2015
0
11
Two new pill-only regimens that rapidly cure most patients with genotype 1 hepatitis C (HCV) infection could soon be widely prescribed across Europe. Two recently-published studies1,2 confirmed the efficacy and safety of ...
Oct 17, 2014
0
0
An NIH-led team of scientists has discovered a new vulnerability in the armor of HIV that a vaccine, other preventive regimen or treatment could exploit. The site straddles two proteins, gp41 and gp120, that jut out of the ...
Sep 3, 2014
0
0
